Vsee Health, Inc. (VSEE) Stock Price & Analysis
Vsee Health, Inc. (VSEE) fell 4.61% to USD 0.16 as of June 10, 2026 at 03:37 UTC, according to Nexqual real-time market data.
VSEE last closed at USD 0.16; the session ranged USD 0.15–0.17 on volume of 2,122,667 shares. Market capitalization is $7.63M, with a 52-week range of USD 0.15–2.52 (NCM). Source: Nexqual, June 10, 2026 at 03:37 UTC.
Key Statistics (as of June 10, 2026 at 03:37 UTC)
| Price | USD 0.16 |
|---|---|
| Change | ▼ 4.61% (down) |
| Previous Close | USD 0.16 |
| Open | USD 0.16 |
| Day Range | USD 0.15 – 0.17 |
| 52-Week Range | USD 0.15 – 2.52 |
| Volume | 2,122,667 shares |
| Market Cap | $7.63M |
| Exchange | NCM |
Technical Analysis (VSEE)
Nexqual's technical model rates VSEE "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.62 (neutral) |
| vs SMA50 | Below (USD 0.2) |
| MACD | -0.01 (negative) |
Analyst Ratings (VSEE)
Wall Street analysts rate VSEE "None", per Nexqual as of June 10, 2026 at 03:37 UTC.
| Consensus Rating | None |
|---|
Earnings (VSEE)
Source: Nexqual, June 10, 2026 at 03:37 UTC.
Financials & Fundamentals (VSEE)
| Total Revenue | $14.46M |
|---|---|
| Revenue Growth (YoY) | -4.90% |
| Gross Margin | +46.30% |
| Operating Margin | -94.12% |
| Profit Margin | -92.37% |
| ROE | -945.70% |
| Debt / Equity | 33.78 |
| Current Ratio | 0.41 |
| Total Cash | $1.35M |
| Total Debt | $2.14M |
| Free Cash Flow | $-5.43M |
Source: Nexqual, June 10, 2026 at 03:37 UTC.
Financial Health Score (VSEE)
Nexqual rates Vsee Health, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:37 UTC.
| Growth | Weak — Revenue -5% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $1M cash vs $2M debt |
| Cash Flow | Weak — Operating cash flow -$5M |
| Efficiency | Critical — ROE -946%, ROA -34.9% |
Ownership (VSEE)
| Insider Ownership | +11.06% |
|---|---|
| Institutional Ownership | +11.32% |
| Shares Outstanding | 48.60M |
| Float | 34.50M |
| Short % of Float | +4.76% |
Source: Nexqual, June 10, 2026 at 03:37 UTC.
Major Backers & Investors (VSEE)
Notable institutional backers of Vsee Health, Inc. include Armistice Capital, LLC, Fidelity, Cygnus Capital Advisors, LLC, according to Nexqual as of June 10, 2026 at 03:37 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Armistice Capital, LLC | 7.2% |
| Fidelity | 0.82% |
| Cygnus Capital Advisors, LLC | 0.25% |
| Xtx Topco Ltd | 0.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.9% |
| Vanguard Group | 0.88% |
Source: Nexqual, June 10, 2026 at 03:37 UTC.
From Vsee Health, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- For example, the laws of the State of California, in which we operate, are more restrictive than HIPAA, including the provisions of the California Consumer Privacy Act, or CCPA, which went into effect January 1, 2020.
- In addition, we have developed channel customers who incorporate our platform as part of a model that combines on-site staffing solutions with telemedicine   The direct sales organization is supported by marketing and customer success specialists.
- Setting up telehealth is often a complex experience, but our system allows fast setup and go live by which healthcare providers can:                       VSee supports efficient team coordination by allowing healthcare providers to:           4 Table of Contents   Our Administrative Features .
- We have developed a comprehensive quality management program that supports evidence-based practices, tracks customer satisfaction levels and encourages continuous improvement of telemedicine services.
Partnerships
- We have developed a unique quality control program in collaboration with each hospital by development of a hospital specific reporting dashboard to monitor and achieve high quality critical care quality.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BENF | Beneficient | USD 3.44 | ▼ 2.82% |
| SCNX | Scienture Holdings, Inc. | USD 0.37 | ▲ 1.67% |
| AMIX | Autonomix Medical, Inc. | USD 0.4 | ▼ 1.29% |
| XHLD | TEN Holdings, Inc. | USD 1.2 | ▼ 16.08% |
| MIRA | MIRA Pharmaceuticals, Inc. | USD 0.98 | ▼ 2.3% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:37 UTC. This page is informational and not investment advice.